The Psilocybin Behavioral Health Access and Services Act establishes a comprehensive legal framework for the regulated production, use, and administration of psilocybin in New Jersey, specifically for individuals aged 21 and older. The bill decriminalizes psilocybin-related offenses and allows for the expungement of past convictions, recognizing the potential therapeutic benefits of psilocybin for various behavioral health conditions. It mandates the creation of a Psilocybin Advisory Board within the Department of Health to oversee the implementation and regulation of psilocybin services, which includes establishing safe and affordable service centers, licensing requirements, and public education initiatives. The act also emphasizes the importance of a regulatory framework to ensure safety and compliance, including the establishment of a tracking system for psilocybin products.

Additionally, the bill outlines specific licensing requirements for psilocybin service centers and product manufacturers, including the introduction of a microbusiness license with reduced fees. It prohibits the sale of psilocybin products to visibly intoxicated individuals and mandates that consumption occurs only under the supervision of licensed facilitators. The Department of Health is tasked with regulating the industry, including the issuance of psilocybin worker permits, and ensuring that safety standards are met. Legal protections are provided for individuals and entities involved in psilocybin services, shielding them from liability under state drug laws. Overall, the legislation aims to promote safe access to psilocybin as a therapeutic option while prioritizing public health and safety.